Last reviewed · How we verify
NCT06219785
Low-intensity Shockwave Therapy for Post-radical Prostatectomy Erectile Dysfunction
NA trial testing Low-Intensity Shockwave therapy (LiSWT) in Erectile Dysfunction Following Radical Prostatectomy in 5 participants. Terminated before completion.
1 October 2024
Quick facts
| Lead sponsor | The Methodist Hospital Research Institute |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 10 January 2024 |
| Primary completion | 1 October 2024 |
| Estimated completion | 1 October 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Low-Intensity Shockwave therapy (LiSWT)
Conditions studied
- Erectile Dysfunction Following Radical Prostatectomy — all drugs for Erectile Dysfunction Following Radical Prostatectomy →
Sponsor
The Methodist Hospital Research Institute
Who can join
Adults 45 to 70, male only, with Erectile Dysfunction Following Radical Prostatectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research study is trying to determine if Low-Intensity shock wave therapy (LiSWT) is safe and effective in patients with symptoms of erectile dysfunction (ED) after radical prostatectomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06219785
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Erectile Dysfunction Following Radical Prostatectomy
Currently open trials in the same condition.
- NCT07520916 — The Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical Prostatec · NA · recruiting
- NCT06605508 — Regenerative Injection of Stem Cells or Stem Cell-derived Exosomes for Erectile Dysfunction (RISE) · recruiting
- NCT07101731 — Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy · NA · recruiting
- NCT06875258 — PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II) · Phase 4 · recruiting
- NCT05558007 — Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients · Phase 2 · recruiting
Other The Methodist Hospital Research Institute trials
Trials by the same sponsor.
- NCT07048314 — Stem Cells for Erectile Dysfunction Post RALP · Phase 1, PHASE2 · not yet recruiting
- NCT07283068 — IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA · NA · not yet recruiting
- NCT07218484 — VoiceLove Digital Therapy for Delirium in the ICU · NA · recruiting
- NCT07050771 — Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery · Phase 2 · recruiting
- NCT07182279 — Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06219785 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Methodist Hospital Research Institute
- Last refreshed: 8 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06219785.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing